Zafgen (Cambridge, MA) a clinical-stage biopharmaceutical company focused on small molecule therapeutics for the treatment of obesity, closed a $33M Series C financing. Participants include Atlas Venture and Third Rock Ventures.
Thanx for your patience as we catch-up.

Monteria Medical (Canada) a development-stage medical device company focused on laser interstitial thermal therapy for the treatment of brain tumors, closed a $8.6M Series C financing. Participants include Business Development Bank of Canada and Southwest Michigan First.
Thanx for your patience as we catch-up.

NABsys (Providence, RI) a development stage dna sequencing company focused on nanopore arrays that can do not require amplification or labeling, closed a $10M Series C financing. Participants include Stata Venture.
Thanx for your patience as we catch-up.

Averdo (Waltham, MA) a commercial-stage ophthalmology medical device company focused on procedures for biomechanically strengthening and modifying the cornea, closed on $25M Series C financing. Participants include SCP Vitalife, Aperture Venture Partners, Prism VentureWorks, De Novo Ventures, Flagship Ventures, Borealis Ventures and Echelon Ventures.
Thanx for your patience as we catch-up.

OPX Biotechnologies (Boulder, CO) a development-stage biofuels company using synthetic biology to engineer the microbes as a bio-acrylic renewable fuel source, closed a $36.5M Series C financing. Participants include US Renewables Group, DBL Investors, Mohr Davidow Ventures, Braemar Energy Ventures, Altira Group and X/Seed Capital.
Thanx for your patience as we catch-up.

Horizon Discovery (United Kingdom) a commercial-stage translational genomics company focused on drug discovery and molecular diagnostics, closed a $18.6M Series C financing. Participants include MVM Life Sciences, DFJ Esprit and Roche Venture Fund.
Thanx for your patience as we catch-up.

Restoration Robotics (Mountain View, CA) a clinical-stage medical device company focused on computer assisted image-guidance for hair follicle harvesting, closed a $41M Series C financing. Participants include Clarus Ventures, Sutter Hill Ventures, Alloy Ventures and Interwest.
Thanx for your patience as we catch-up.

LifeBond (Israel) a clinical-stage medical device company focused on surgical hemostats, sealants and coagulation, closed a $20M Series C financing. Participants include Giza Venture Capital, Aurum Ventures, Johnson & Johnson Development Corp. and Pitango Venture Capital.
Thanx for your patience as we catch-up.

ZocDoc (New York, NY) a commercial-stage web-based healthcare provider network and appointment service, closed a $25M Series C, bringing the total financing to $75M. Participants inculde Goldman Sachs and DST Global.

Clinipace Worldwide (Durham, NC) a commercial-stage global digital clinical research organization specializing in strategic product and clinical development, closed a $15M Series C financing. Participants include Morgan Stanley, Hatteras Venture Partners and Brook Private Equity Advisors.
The 3Q11 OnBioVC Trend Analysis Will Be Available Next Monday 31 October

Crescendo Bioscience (San Francisco, CA) a commercial-stage molecular diagnostics company focused on quantitative biomarker tests for rheumatoid, closed a $31M Series C financing. Participants include Aeris Capital, Mohr Davidow Ventures and Kleiner Perkins Caufield & Byers.

Valeritas (Bridgewater, NJ) a commercial-stage developer of a disposable insulin delivery device, closed a $150M Series C financing. Participants include Welsh, Carson, Anderson & Stowe, MPM Capital, Pitango Venture Capital, Abingworth Management, Advanced Technology Ventures, Onset Ventures, HLM Venture Partners, Agate Medical Investments, CHL Medical Partners and Kaiser Permanente Ventures.

Putney (Portland, ME) a commercial-stage pharmaceutical company focused on bioequivalents and specialty drugs for the veterinary market, closed a $21M Series C financing. Participants include NewSpring Health Capital and Safeguard Scientifics.